Review





Similar Products

96
Miltenyi Biotec cd3 agonist
Cd3 Agonist, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd3/CD3+Antibody%2C+anti-human/pm43003131-128-22-26
Average 96 stars, based on 1 article reviews
cd3 agonist - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
ABclonal Biotechnology anti human cd3 antibody
KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Anti Human Cd3 Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd3/CD3+epsilon+Rabbit+mAb/pmc13770899-76-10-14
Average 94 stars, based on 1 article reviews
anti human cd3 antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

97
Bio X Cell hamster anti cd3
KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Hamster Anti Cd3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd3/InVivoMAb+anti-mouse+CD3%CE%B5/pm43015374-980-7-11
Average 97 stars, based on 1 article reviews
hamster anti cd3 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

94
R&D Systems clone ucht1
KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Clone Ucht1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd3/Human+CD3+epsilon+Antibody/pmc13761384-42-19-21
Average 94 stars, based on 1 article reviews
clone ucht1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology anti hdac3
KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Anti Hdac3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd3/CD3-%CE%B5+Antibody/pmc13770643-106-15-20
Average 94 stars, based on 1 article reviews
anti hdac3 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Proteintech anti cd3
KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Anti Cd3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd3/CL594-conjugated+CD3+Antibody/pm43001027-42-46-47
Average 93 stars, based on 1 article reviews
anti cd3 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
Proteintech cd3
KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Cd3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd3/CD3+Antibody/pm43002206-201-18-19
Average 96 stars, based on 1 article reviews
cd3 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Elabscience Biotechnology surface markers cd3 percp cyanine5 5
KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Surface Markers Cd3 Percp Cyanine5 5, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd3/PerCP/10__1096_slash_fj__202603362rr-117-6-11
Average 96 stars, based on 1 article reviews
surface markers cd3 percp cyanine5 5 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Elabscience Biotechnology fluorochrome conjugated antibodies against cd3
KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Fluorochrome Conjugated Antibodies Against Cd3, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd3/APC+Anti-Mouse+CD3+Antibody/10__1096_slash_fj__202603362rr-109-7-13
Average 94 stars, based on 1 article reviews
fluorochrome conjugated antibodies against cd3 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Proteintech anticd3
KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Anticd3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd3/CD3+Antibody/10__1038_slash_s41598___026___74217___9-242-43-46
Average 96 stars, based on 1 article reviews
anticd3 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Journal: Journal of Extracellular Vesicles

Article Title: CD8a‐Functionalized Red Blood Cell Membrane Nanovesicles Delivering KRN2 for Coordinated T Cell Reinvigoration and Macrophage Metabolic Reprogramming in Cardia Cancer

doi: 10.1002/jev2.70384

Figure Lengend Snippet: KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Article Snippet: The isolated cells were first stimulated overnight with 2 μg/mL anti‐human CD3 antibody (A19017, ABclonal, China), followed by co‐stimulation with 2 μg/mL anti‐CD28 antibody (A20346, ABclonal, China) and recombinant human IL‐2 (rhIL‐2, 100 U/mL; #200‐02, PeproTech, USA) at 37°C for an additional 48 h. After stimulation, the cells were transferred to new culture plates containing fresh RPMI 1640 medium (11875093, Gibco, USA) supplemented with 10% fetal bovine serum (FBS), 1% penicillin‐streptomycin (15070063, Gibco, USA), and 1% L‐glutamine (25030081, Gibco, USA).

Techniques: Expressing, Isolation, Activation Assay, Quantitative RT-PCR, Western Blot, Knockdown, Luciferase, Activity Assay, Binding Assay, Cell Counting